Catalyst
Slingshot members are tracking this event:
Alnylam Filed a Clinical Trial Application (CTA)with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for ALN-GO1; plans to initiate a Phase 1 study with ALN-GO1 in early 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALNY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 09, 2016
Occurred Source:
http://www.businesswire.com/news/home/20160309005129/en/Alnylam-Initiates-Phase-12-Clinical-Trial-ALN-GO1
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Cta, Mhra, Aln-go1, Hyperoxaluria Type 1
